BA.2, driven to near-zero levels by BA.5, still haunt us, spawning monstrous viruses that, after vanishing for months, burst forth, gnarled & hideous, in novel antibody armor. The latest, which I found skulking around India, has 13 spike mutations. 1/28 github.com/cov-lineages/p…
There have been just 4 sequences so far, but they’ve been in Indian cities roughly 800-1300 km apart from each other. Spike mutations consist of three deletions + 10 amino acid substitutions, two of which (K478T & R493Q) are reversions. 2/28
Most of these mutations are familiar, & known for their antibody-evading properties. The most unique are the K478T reversion & R1091H, an uncommon S2 mutation. But in this thread, I want to discuss the three new deletions, all in the amino-terminal domain (NTD). 3/28
The NTD, at spike-protein amino acid (AA) sites 14-306, is possibly the most variable region in the SARS-CoV-2 genome, but the reasons for NTD mutations are usually less clear than for the receptor-binding domain (RBD, sites 331-528). 5/28
The RBD binds the ACE2 receptor on human cells & is the primary target of neutralizing antibodies, & most mutations there can be attributed to the effect they have on ACE2 affinity and/or antibody evasion. 6/28
The NTD is, to a lesser extent, also targeted by antibodies, primarily at the NTD antigenic supersite. The NTD contains five loops that extend outward, known as N1, N2, N3, N4, & N5. Loops N1, N3, & N5 largely form the NTD supersite. 7/28
At precisely what amino acid sites are these NTD loops located?
• N1 Loop—14-26
• N2 Loop—67-81
• N3 Loop—140-158
• N4 Loop—174-188
• N5 Loop—241-263 embopress.org/doi/full/10.15…
8/28
As described below, SARS-CoV-2’s NTD loops are long compared to those of other sarbecoviruses, especially N2, N3, & N5. It is precisely at these loops that we see the vast majority of NTD deletions in SARS-CoV-2. 9/28
NTD deletions, by shortening the length of these projecting loops, can help SARS-CoV-2 evade antibodies, a fact first proven by @mccarthy_kr. He showed this, impressively, before any VOC with deletions had yet emerged. 10/28 science.org/doi/10.1126/sc…
But there is more to these NTD deletions than just immune evasion. The most common deletion has been ∆69-70—found in Alpha, BA.1, BA.4/5, & others—and it plays little to no role in immune evasion. 11/28
Variations in NTD-loop length through deletions & insertions turn out to be common in other sarbecoviruses, suggesting their broad utility at facilitating evolutionary change, possibly by compensating for changes caused by mutations elsewhere. 12/28
For example, @GuptaR_lab found that ∆69-70 usually accompanied RBD mutations (like N439K &Y453F) that strengthen ACE2 binding and/or evade immunity but which also reduce viral infectivity. 13/28
∆69-70, inserted into pseudoviruses, increased infectivity & when H69/V70 residues were re-inserted back into Alpha, cell entry, S1/S2 spike cleavage (an essential step in entry), & ability to fuse cells (form syncytia) were all greatly impaired. 14/28
More generally, deletions that shorten NTD loops appear to greatly increase the ability of SARS-CoV-2 to fuse with cell membranes, infect cells, and fuse cells together. 15/28
SARS1 has much shorter NTD loops than SARS2. @EnyaQing found that replacing the SARS2 NTD with the SARS1 NTD in virus-like particles (VLP) enormously increases its ability to fuse with cell membranes and infect cells. 16/28
Similar results were found by @GroveLab when replacing SARS-CoV-2’s NTD with that of Pangolin CoV, which has very short NTD loops. 17/28
By exposing VLP’s to dissolved ACE2 receptors, one can determine the degree to which RBDs are in the exposed “up” position, which is necessary for binding ACE2. The more a VLP is inhibited from fusing w/cell-like particles by dissolved ACE2, the greater the RBD exposure. 18/28
It turns out that by this measure, SARS-CoV-1 NTD—which, again, has much shorter NTD loops than SARS-CoV-2 & is therefore a good proxy for SARS-CoV-2 viruses bearing many deletions—enhances RBD exposure. 19/28
So if shorter NTD loops improves cell entry, fusion with cell membranes, the ability to fuse cells together (syncytia formation), and RBD exposure, why don’t all SARS-CoV-2 have large deletions, shortening their NTD loops? 20/28
NTD deletions must exact a cost, & that cost is spike-protein instability. Putting the SARS2+SARS1-NTD VLP’s through a mildly stressful procedure resulted in the loss of the S1 portion of spike, destroying cell entry & fusion capability. 21/28
So NTD deletions often confer antibody-evading powers and can powerfully increase a virus’s ability to infect cells and fuse cells together, but this comes at the cost of spike instability, leaving it vulnerable to permanent inactivation. 22/28
What determines whether a given NTD deletion will be deleterious or advantageous? The environment of course, most powerfully, the spike protein background. “The impact of NTD hypervariability depends on the S protein background.” 23/28
In fact, it was only after the D614G mutation stabilized spike that NTD deletions became possible. The authors of this study—which is impossible to do justice to here—issued an ominous & prescient warning (written in May 2021, before Delta’s properties were known). 24/28
“That a genetic drift around metastable set points can potentially generate hyper-fusogenic CoVs with enhanced cell entry potential is an important consideration in understanding CoV cell entry, transmission, & pathogenicity.” Indeed. 25/28
Will this particular BA.2 monstrosity, or any of the others, turn out to be hyper-fusogenic, with Delta-like disease severity? My guess is not simply because they retain the Omicron S2, which seems to annihilate all fusogenicity. 26/28
But a reversion to greater fusogenicity, LRT tropism, & Delta-like disease severity seems extremely likely at some point. We would do well to acknowledge this & recognize the necessity of instituting serious NPIs when it happens. 27/28
As usual, I want to emphasize that I’m not an expert in these matters and have no formal credentials. It’s entirely possible I’ve misinterpreted something in this thread, and I welcome corrections and comments from all. 28/28
Finally, thank you to all the hard-working scientists throughout the world sequencing & uploading virus sequences, without which surveillance would be impossible—@r_karyakarte, for example. And thanks to @GISAID for organizing & storing these sequences so they can be monitored.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Agree, several weeks' respite seems likely. Variant-chasing may be hopeless, but could mutation-chasing be possible? With so much convergent evolution in spike, esp. RBD, would it be possible to include mutations (346, 356, 444, 460, 486, 490) in anticipation of their rise? 1/10
Even as monstrous new variants like BA.2.3.20, BJ.1, BH.1, BP.1, & BA.2.75 sublineages emerge at a staggering frequency, there seems to be enough similarity between them in antigenically important locations to be useful in vaccine design. 2/10
And the fastest-growing BA.5 lineages all have R346T (BF.7, BA.5.2.6) or K444T/M/N/R (BE.1.1.1, BA.5.6.2, BA.5.2.7). BQ.1 (BE.1.1.1 + N460K), spotted by @siamosolocani, seems to me the most formidable of the bunch. 3/10
Today I discovered an extraordinary microlineage of BA.2.3. What makes it extraordinary? A colossal genetic saltation (10 spike mutations) combined with striking geographic spread for a very small number of sequences (just 4 so far). 1/25 github.com/cov-lineages/p…
First the mutations on top of BA.2.3:
Spike—M153T, N164K, H245N, G257D, K444R, N450D, L452M, N460K, A484R, R493Q
ORF1a—T727I, A1049V, I1714T, M2169V, T2174I, T2648I, Q3922R
ORF1b—T1404M
ORF9b—D83E 2/25
A484R is particularly worth noting. S:484 has long been known as one of the most important antigenic sites of all. But R484 has been extremely rare. Why? It’s yet another 2-nucleotide mutation. We saw this with F486P in BA.2.10.4. 3/25
I think this is probably the fastest growing of the K444X variants. Spike K444 is the biggest remaining RBD escape mutation for BA.5, and four main versions are circulating: K444N, K444R, K444T, and K444M. 1/15
K444 is the most prominent remaining escape location for BA.5 on the spike receptor binding domain (RBD), the primary target for antibodies, so any lineage with mutations here is worth monitoring. Chart courtesy of @jbloom_lab's RBD escape calculator. jbloomlab.github.io/SARS2_RBD_Ab_e… 2/15
K444N and K444R got a head start on T & M, possibly because both involve nucleotide mutations that are more common than those involved in the latter two. Nucleotide frequencies provided by @alchemytoday & diagrams courtesy of @nextstrain's wonderful Nextclade site. 3/15
Inverse relationship between rhinovirus & SARS-CoV-2 still holding strong. Seems clear some form of viral interference is happening here. But is the causation all one way (SARS2-->RV) or does it go both ways? As someone likely suffering an RV infection right now, I'm curious 1/10
There is some evidence that rhinovirus infection protects against Covid by activating interferon-stimulated genes (ISG). ISG are activated upon SARS-CoV-2 infection as well, but with a delay that allows the virus to replicate & establish infection. 2/10 rupress.org/jem/article-st…
Here's another 2021 study showing experimental evidence that RV impedes Covid. Remarkably, SARS-CoV-2 was inhibited even when rhinovirus was introduced 24 hours after inoculation. 3/10 academic.oup.com/jid/article/22…
Here's a quandary for you: Below are the weekly growth advantages of BA.5.2 relative to BA.5.1 in Denmark, the UK, and the USA since July 1.
Denmark—33% (CI: 29-38%)
UK—13% (CI: 11-16%)
USA—0% (CI: -2-2%) 1/10
The existence of a large growth advantage for BA.5.2 over BA.5.1 (found in most countries) is a bit of a conundrum to begin with. BA.5.2 and BA.5.1 originally differed by just one amino acid in the obscure ORF9b protein sector of the genome. 2/10 pango.network/summary-of-des…
But as pointed out by the indefatigable @siamosolocani, a growing majority of BA.5.2 sequences have ORF1b:T1050N, which seems to grant a ~10% weekly growth advantage to BA.5.2 sequences that have it. (Same figures for Denmark & USA are 8% & 9%.) 3/10
BA.5.6.2 (BA.5.6 + S:K444T) just designated. The BA.5 + K444 sublineages have been growing steadily for weeks now—predictably. Several others are on the rise as well. 1/9 github.com/cov-lineages/p…
Why predictably? Because K444 is the largest RBD escape mutation codon on a BA.4/5 background, as shown by the ever-useful Bloom Lab RBD escape calculator. 2/9 jbloomlab.github.io/SARS2_RBD_Ab_e…
If/when K444T & K444N spread widely, it will be the death knell of bebtelovimab, the last monoclonal antibody treatment left standing. V445F and V445A are becoming more common as well, and they also render bebtelovimab virtually useless. 3/9 fda.gov/media/156152/d…